UnitedHealth Group: Uncertainties Through 2025 Reiterate Buy Opportunity

RapidEye We previously covered UnitedHealth Group (NYSE:UNH) in March 2024, discussing why it was an even more attractive Buy after the regulatory probe/cyberattack, as the discounted valuations and stock pullback offered expanded upside potential and dividend yields for an improved margin of safety. While there might be near-term headwinds ahead, attributed to the potential regulatory fines, lawsuits, and increased spending on cybersecurity, we maintained our belief that these issues were likely to be  ...